The surgery was very difficult due to the size of the tumor and its attachment to the intestines, bladder and other organs.

"I burst out crying and said 'can I leave?'. I walked out of my appointment and the next day I asked myself what we could do.

During a live event, Tony Philip, MD, and participants discussed molecular profiling and active surveillance for desmoid ...

Plexiform fibromyxoma is a rare primary mesenchymal tumor of the gastrointestinal tract, first reported by Takahashi in 2007 and officially recognized as a subtype of gastric mesenchymal tumor by the ...

Dr. Breelyn Wilky discusses challenges that patients with GIST face and shares advice with those who feel overwhelmed by the ...

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug ...

Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.

Breelyn Wilky, MD, discusses what key molecular insights in GIST management community oncologists should prioritize today.

Recent advances in the biological and molecular understanding of rare uterine tumors have expanded therapeutic options for patients. Uterine cancers are a highly heterogeneous group of cancers ...

Karla Flores was diagnosed with a rare brain tumor. A misplaced MRI found a second, nearly inoperable, tumor on her spine.

Background: Prior studies of metastatic gastrointestinal stromal tumors (mGIST) have largely focused on 5-year survival when evaluating long-term outcomes, but factors underlying longer-term survival ...